Navigation Links
CV Therapeutics Reports 2007 Third Quarter Financial Results
Date:11/6/2007

PALO ALTO, Calif., Nov. 6 /PRNewswire-FirstCall/ -- CV Therapeutics, Inc. (Nasdaq: CVTX) today reported financial results for the third quarter ended September 30, 2007.

For the quarter ended September 30, 2007, the Company reported a net loss of $34.2 million, or $0.58 per share. This compares to a net loss of $62.7 million, or $1.23 per share, for the same quarter in 2006 and $57.6 million, or $0.97 per share, for the prior quarter ended June 30, 2007.

For the quarter ended September 30, 2007, the Company recorded total revenues of $19.8 million which consisted of $18.4 million of net product sales of Ranexa(R) (ranolazine extended-release tablets) and $1.3 million of collaborative research revenue. The $18.4 million of net product sales of Ranexa in the quarter ended September 30, 2007 represents an increase of 20 percent compared to the $15.3 million of net product sales recorded in the prior quarter ended June 30, 2007 and an increase of 124 percent compared to the $8.2 million of net product sales in the same quarter of the prior year. Net product sales recognized in the quarter ended September 30, 2007 includes $1.1 million resulting from a reduction in our estimate of future product returns due to limited actual returns from customers since launch and other factors which impact our estimate of future returns. The third quarter 2007 collaborative research revenue includes revenue primarily related to the reimbursement of certain regadenoson development costs from our collaborative partner.

Total revenues for the nine months ended September 30, 2007 of $60.4 million consisted of $45.7 million of net product sales of Ranexa and $14.7 million of collaborative research revenue which includes a $7.
'/>"/>

SOURCE CV Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Prime Therapeutics Receives TIPPS Certification
2. Adams Respiratory Therapeutics to Celebrate 10th Anniversary of its Incorporation on September 12
3. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
4. Lorus Therapeutics announces election of three new Directors and appoints a new Chairman
5. Deane F. Johnson Center for Neurotherapeutics to Launch First Mobile Medical Unit on October 4th
6. Russell Investment Group Advises Protalix Biotherapeutics of Index Adjustment
7. Adams Respiratory Therapeutics Announces FDA Approval of Grape-Flavored Delsym(R)
8. Prime Therapeutics Announces URAC Accreditation
9. Cell Therapeutics, Inc. (CTI) to Present at BIO Investor Forum
10. Horizon Therapeutics, Inc. Scheduled to Present at Upcoming BioPartnering Europe Meeting
11. Sontra Medical Corporation Changes Name to Echo Therapeutics, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2014)... 27, 2014 AlignLife, a chiropractic ... the kick-off of its annual Toy Drive. With ... go to donate to those in need throughout ... organizations to distribute the donations to those most ... locations will be accepting donations at the clinics ...
(Date:11/26/2014)... November 27, 2014 Recently, DressVe ... special occasion dresses, has unveiled its 2014 Cyber Monday ... these new dresses, up to 90 percent off. The ... Dec. 3. Free delivery is provided for orders above ... women’s dresses, shoes, handbags and other fashion accessories. The ...
(Date:11/26/2014)... 27, 2014 Boxing Day is traditionally ... would receive gifts, known as a "Christmas box", from ... , With the coming of Boxing Day, some people ... smart before every business opportunity, and it has recently ... a site-wide promotion for its global customers. Then people ...
(Date:11/26/2014)... Norwalk Hospital is pleased to ... by the American Nurses Credentialing Center (ANCC). , ... of work environments where nurses can flourish. The ... Norwalk Hospital and identifies it as one of ... an organizations’ commitment to nurses and their contributions ...
(Date:11/26/2014)... Alex Kramer HealthDay ... People with rheumatoid arthritis may be more likely to achieve ... new research. The study found that those who were ... Being underweight also lowered the odds of remission. "Medication ... population," said Dr. Susan Goodman, the study,s lead author and ...
Breaking Medicine News(10 mins):Health News:DressVe.com: Best 2014 Special Monday Sales Online 2Health News:Tbdress.com: Best Boxing Day Sales For Ladies Worldwide 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 2Health News:Norwalk Hospital Announces American Nurses Credentialing Center PATHWAY TO EXCELLENCE® DESIGNATION 3Health News:Weight Could Influence Rheumatoid Arthritis Relief 2Health News:Weight Could Influence Rheumatoid Arthritis Relief 3
... students and junior medical doctors of the Medical College ... have decided to not to run the outpatient departments ... doctors have however promised not to cause any inconvenience ... a ‘parallel OPD’s’ for the benefit of patents. A ...
... substance inside the body of a lobster commonly known as ... may others as a waste//, unhealthy product. The health agency ... eating too much of lobster tomalley. ,The health ... as a liver and pancreas for lobster, can sometimes contain ...
... anti-reservation medicos strike in India, the government on Sunday night ... on quota in central educational institutes// but the students and ... by calling a bandh in Delhi on May 31. ... talks with Federal Minister Oscar Fernandes who followed it up ...
... issue has been put on the national agenda by India's ... more pressing problems. // ,Sam Pitroda was right ... selecting students for institutions of higher education. But his suggested ... (IITs) is not feasible. Already, the existing IITs are facing ...
... The new interim head of the World Health Organization (WHO), ... since assuming office // , confirmed that Dr Anders Nordstrom. ... the support from the people to continue the fight against ... would continue the work of his predecessor Dr Lee Jong-wook, ...
... AIDS. It is waiting for the FDA to give it ... Nasdaq-listed company already sells the kit to hospitals and public ... product would become an important weapon to fight against HIV. ... was made. Statistics show that more than one million Americans ...
Cached Medicine News:Health News:Agitating Doctors Call For Two Day Shut Down Of OPD’ 2Health News:Quota System: Diverting Attention From The Real Problem 2Health News:Quota System: Diverting Attention From The Real Problem 3Health News:Quota System: Diverting Attention From The Real Problem 4
(Date:11/26/2014)... N.C. , Nov. 25, 2014  At the ... Antonio this October, KaVo Kerr Group was ... Technology Expo, offering attendees the opportunity to see and ... well-respected key opinion leaders deliver lectures on the latest ... Group products include the new DEXIS CariVu Caries Detection ...
(Date:11/26/2014)... 25, 2014  Medtronic,s roughly $43 billion ... widely discussed in the media for its US ... stronger leading player in one of the fastest ... healthcare market research firm said  the two companies ... diverse set of solutions spanning inpatient to home ...
(Date:11/26/2014)... 25, 2014  Unilife Corporation (NASDAQ: UNIS, ASX: UNS), ... systems, today announced that its Chairman and CEO, ... Piper Jaffray 26th Annual Healthcare Conference at the New ... December 2, 2014. The conference presentation ... listen only Webcast. To listen, please go to: ...
Breaking Medicine Technology:KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 2KaVo Kerr Group Showcased in Pride Institute Technology Expo at ADA Annual Meeting 3Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 2Medtronic - Covidien: Beyond Taxes, Deal Will Create Patient Monitoring Power, according to Kalorama Information 3Unilife to Present at the Piper Jaffray 26th Annual Healthcare Conference on December 2nd 2
... 2011 Astellas Pharma Inc. (TSE: 4503) ... to conduct, in conjunction with executive management, a review of ... Prosidion was acquired as part of Astellas, acquisition of OSI ... two drug candidates in development for diabetes and obesity, as ...
... Calif., Jan. 10, 2011 Questcor Pharmaceuticals, Inc. ... to 2010.  The Company estimates that 353 new, paid Acthar ... and shipped during the quarter, up 66% from the year ... 2010.  1,680 vials and 6,666 vials of the company,s principal ...
Cached Medicine Technology:Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 2Astellas to Review Strategic Business Alternatives for Prosidion Subsidiary 3Questcor Pharmaceuticals Reports Strong Finish to 2010 2Questcor Pharmaceuticals Reports Strong Finish to 2010 3Questcor Pharmaceuticals Reports Strong Finish to 2010 4Questcor Pharmaceuticals Reports Strong Finish to 2010 5
... Biotechnology, Genomic and Proteomic users should ... over Sample Preparation capability for run-to-run ... ventilated centrifuge accommodates 4x750 ml up ... throughput. High throughput screening, research and ...
... common sight in laboratories everywhere, Model ... dependable centrifuge standards for decades in ... Model K's simple, classic design and ... a standard for centrifuge performance, reliability ...
Inquire...
... Use of the Hybridization Oven/Shaker rigidly ... ensuring the stringency of hybridization and ... and reproducible probing of nucleic acids ... Developed for use with radioactive and ...
Medicine Products: